These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 15780413

  • 1. Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study.
    Kartsonis NA, Saah AJ, Joy Lipka C, Taylor AF, Sable CA.
    J Infect; 2005 Apr; 50(3):196-205. PubMed ID: 15780413
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort.
    Hiemenz JW, Raad II, Maertens JA, Hachem RY, Saah AJ, Sable CA, Chodakewitz JA, Severino ME, Saddier P, Berman RS, Ryan DM, Dinubile MJ, Patterson TF, Denning DW, Walsh TJ.
    Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1387-94. PubMed ID: 20703506
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
    Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB, Sable CA, Kartsonis NA, Ngai A, Taylor A, Patterson TF, Denning DW, Walsh TJ, Caspofungin Salvage Aspergillosis Study Group.
    Clin Infect Dis; 2004 Dec 01; 39(11):1563-71. PubMed ID: 15578352
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II, Hanna HA, Boktour M, Jiang Y, Torres HA, Afif C, Kontoyiannis DP, Hachem RY.
    Leukemia; 2008 Mar 01; 22(3):496-503. PubMed ID: 18094720
    [Abstract] [Full Text] [Related]

  • 7. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
    Aliff TB, Maslak PG, Jurcic JG, Heaney ML, Cathcart KN, Sepkowitz KA, Weiss MA.
    Cancer; 2003 Feb 15; 97(4):1025-32. PubMed ID: 12569602
    [Abstract] [Full Text] [Related]

  • 8. Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation.
    Kriván G, Sinkó J, Nagy IZ, Goda V, Reményi P, Bátai A, Lueff S, Kapás B, Réti M, Tremmel A, Masszi T.
    Acta Biomed; 2006 Feb 15; 77 Suppl 2():17-21. PubMed ID: 16918062
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.
    Betts R, Glasmacher A, Maertens J, Maschmeyer G, Vazquez JA, Teppler H, Taylor A, Lupinacci R, Sable C, Kartsonis N.
    Cancer; 2006 Jan 15; 106(2):466-73. PubMed ID: 16353208
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.
    Nivoix Y, Zamfir A, Lutun P, Kara F, Remy V, Lioure B, Rigolot JC, Entz-Werlé N, Letscher-Bru V, Waller J, Levêque D, Koffel JC, Beretz L, Herbrecht R.
    J Infect; 2006 Jan 15; 52(1):67-74. PubMed ID: 16368463
    [Abstract] [Full Text] [Related]

  • 12. Combination antifungal therapy for invasive aspergillosis.
    Marr KA, Boeckh M, Carter RA, Kim HW, Corey L.
    Clin Infect Dis; 2004 Sep 15; 39(6):797-802. PubMed ID: 15472810
    [Abstract] [Full Text] [Related]

  • 13. Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study.
    Kartsonis NA, Saah A, Lipka CJ, Taylor A, Sable CA.
    J Antimicrob Chemother; 2004 May 15; 53(5):878-81. PubMed ID: 15044431
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies.
    Kontoyiannis DP, Hachem R, Lewis RE, Rivero GA, Torres HA, Thornby J, Champlin R, Kantarjian H, Bodey GP, Raad II.
    Cancer; 2003 Jul 15; 98(2):292-9. PubMed ID: 12872348
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
    Agarwal MB, Rathi SA, Ratho N, Subramanian R.
    J Assoc Physicians India; 2006 Dec 15; 54():943-8. PubMed ID: 17334012
    [Abstract] [Full Text] [Related]

  • 20. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
    Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, Del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain S.
    Transplantation; 2006 Feb 15; 81(3):320-6. PubMed ID: 16477215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.